Prepared as an outcome of ICMR Subcommittee on <span class="attribute-to-highlight medbox">Non</span> <span class="attribute-to-highlight medbox">Hodgkin</span>’<span class="attribute-to-highlight medbox">s</span> <span class="attribute-to-highlight medbox">Lymphoma</span> (High Grade) | This consensus document on management of <span class="attribute-to-highlight medbox">non</span>- <span class="attribute-to-highlight medbox">hodgkin</span>’<span class="attribute-to-highlight medbox">s</span> <span class="attribute-to-highlight medbox">lymphoma</span> – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interweaves clinical, biochemical and epidemiological studies.